Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Remedy Pharmaceuticals Inc. is currently managing 2 pending office actions in the Biotechnology & Pharmaceuticals technology area. These 2 pending office actions are split between 2 distinct examiners and 2 distinct art units, showing that even with a small number of active cases, the company's intellectual property is being reviewed in different technical contexts. This distribution suggests that the active matters cover distinct aspects of pharmaceutical technology.
SHIM, DAVID M. is the busiest examiner for the company, currently overseeing 1 pending office action. Because the 2 pending office actions are distributed across 2 distinct examiners, there is no centralization in the examination process. The involvement of 2 distinct art units means that the applicant must be prepared to address the specific guidelines of these specialized groups. Success in the active matters will require tailored responses that account for the individual perspectives of the 2 distinct examiners involved.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SHIM, DAVID M. | 1 | 58.3% | +58.3% |
| THOMAS, TIMOTHY P | 1 | 26.3% | +38.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19191890 | LOW-SORBING GLYBURIDE FORMULATION AND METHODS | THOMAS, TIMOTHY P | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19341379 | LOW-SORBING GLYBURIDE FORMULATION AND METHODS | SHIM, DAVID M. | 75d |
| 19191890 | LOW-SORBING GLYBURIDE FORMULATION AND METHODS | THOMAS, TIMOTHY P | — |
| Art Unit | Apps |
|---|---|
| 1626 | 1 |
| 1614 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19341379 | LOW-SORBING GLYBURIDE FORMULATION AND METHODS | SHIM, DAVID M. | 1626 | §103 | Final Rejection | 75d | Pending | Sep 26, 2025 |
| 19191890 | LOW-SORBING GLYBURIDE FORMULATION AND METHODS | THOMAS, TIMOTHY P | 1614 | §103 | Final Rejection | — | Pending | Apr 28, 2025 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial